Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective.

de Beaurepaire R, Sinclair JMA, Heydtmann M, Addolorato G, Aubin HJ, Beraha EM, Caputo F, Chick JD, de La Selle P, Franchitto N, Garbutt JC, Haber PS, Jaury P, Lingford-Hughes AR, Morley KC, Müller CA, Owens L, Pastor A, Paterson LM, Pélissier F, Rolland B, Stafford A, Thompson A, van den Brink W, Leggio L, Agabio R.

Front Psychiatry. 2019 Jan 4;9:708. doi: 10.3389/fpsyt.2018.00708. eCollection 2018. Review.

2.

Baclofen for the treatment of alcohol use disorder: the Cagliari Statement.

Agabio R, Sinclair JM, Addolorato G, Aubin HJ, Beraha EM, Caputo F, Chick JD, de La Selle P, Franchitto N, Garbutt JC, Haber PS, Heydtmann M, Jaury P, Lingford-Hughes AR, Morley KC, Müller CA, Owens L, Pastor A, Paterson LM, Pélissier F, Rolland B, Stafford A, Thompson A, van den Brink W, de Beaurepaire R, Leggio L.

Lancet Psychiatry. 2018 Dec;5(12):957-960. doi: 10.1016/S2215-0366(18)30303-1. Epub 2018 Nov 6. No abstract available.

3.

Efficacy, tolerability, and safety of low-dose and high-dose baclofen in the treatment of alcohol dependence: A systematic review and meta-analysis.

Pierce M, Sutterland A, Beraha EM, Morley K, van den Brink W.

Eur Neuropsychopharmacol. 2018 Jul;28(7):795-806. doi: 10.1016/j.euroneuro.2018.03.017. Epub 2018 Jun 20.

PMID:
29934090
4.

Can baclofen change alcohol-related cognitive biases and what is the role of anxiety herein?

Beraha EM, Salemink E, Krediet E, Wiers RW.

J Psychopharmacol. 2018 Aug;32(8):867-875. doi: 10.1177/0269881118780010. Epub 2018 Jun 13.

5.

Response to "Baclofen and alcohol use disorders: From miracle to mirage".

Beraha EM, Salemink E, Goudriaan AE, van den Brink W, Wiers RW.

Eur Neuropsychopharmacol. 2017 Jul;27(7):693-694. doi: 10.1016/j.euroneuro.2017.05.002. Epub 2017 May 30. No abstract available.

PMID:
28576349
6.

Speaking fluently with baclofen?

Beraha E, Bodewits P, van den Brink W, Wiers R.

BMJ Case Rep. 2017 May 11;2017. pii: bcr-2016-218714. doi: 10.1136/bcr-2016-218714.

7.

Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: A multicentre, randomised, double-blind controlled trial.

Beraha EM, Salemink E, Goudriaan AE, Bakker A, de Jong D, Smits N, Zwart JW, Geest DV, Bodewits P, Schiphof T, Defourny H, van Tricht M, van den Brink W, Wiers RW.

Eur Neuropsychopharmacol. 2016 Dec;26(12):1950-1959. doi: 10.1016/j.euroneuro.2016.10.006. Epub 2016 Nov 11.

PMID:
27842939
8.

Validation of the Amsterdam Beverage Picture Set: A Controlled Picture Set for Cognitive Bias Measurement and Modification Paradigms.

Pronk T, van Deursen DS, Beraha EM, Larsen H, Wiers RW.

Alcohol Clin Exp Res. 2015 Oct;39(10):2047-55. doi: 10.1111/acer.12853. Erratum in: Alcohol Clin Exp Res. 2016 Jul;40(7):1588.

9.

Implicit Associations and Explicit Expectancies toward Cannabis in Heavy Cannabis Users and Controls.

Beraha EM, Cousijn J, Hermanides E, Goudriaan AE, Wiers RW.

Front Psychiatry. 2013 Jun 21;4:59. doi: 10.3389/fpsyt.2013.00059. eCollection 2013.

10.

Hemispheric asymmetry for affective stimulus processing in healthy subjects--a fMRI study.

Beraha E, Eggers J, Hindi Attar C, Gutwinski S, Schlagenhauf F, Stoy M, Sterzer P, Kienast T, Heinz A, Bermpohl F.

PLoS One. 2012;7(10):e46931. doi: 10.1371/journal.pone.0046931. Epub 2012 Oct 8.

Supplemental Content

Loading ...
Support Center